Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,338 | -1,514 | -524 | 778 | 850 |
| Income taxes - deferred | -9 | -25 | 17 | 342 | 53 |
| Other Working Capital | 19 | 249 | -111 | 2 | -7 |
| Operating Cash Flow | $-2,328 | $-1,290 | $-618 | $1,122 | $896 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,275 | -1,275 | -1,275 | -1,275 | -1,275 |
| Financing Cash Flow | $-1,275 | $-1,275 | $-1,275 | $-1,275 | $-1,275 |
| Beginning Cash Position | 46,859 | 46,859 | 46,859 | 47,012 | 47,012 |
| End Cash Position | 43,256 | 44,294 | 44,966 | 46,859 | 46,633 |
| Net Cash Flow | $-3,603 | $-2,565 | $-1,893 | $-153 | $-379 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,328 | -1,290 | -618 | 1,122 | 896 |
| Free Cash Flow | -2,328 | -1,290 | -618 | 1,122 | 896 |